JS Link Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Public

  • Employees
  • 84

Employees

  • Stock Symbol
  • 127120

Stock Symbol

  • Investments
  • 4

  • Share Price
  • $11.84
  • (As of Friday Closing)

JS Link General Information

Description

JS Link Inc Formerly DNA LINK Inc is a genomic service providing company based in Korea, focusing on research and development in the field of bio-industry and genomic analysis industry.

Contact Information

Formerly Known As
DNA Link
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 31, Magokjungang 8-ro 3-gil
  • Gangseo-gu
  • Seoul, Seodaemun-gu
  • South Korea
+82
Primary Industry
Biotechnology
Other Industries
Other Commercial Products
Stock Exchange
KRX
Vertical(s)
Corporate Office
  • 31, Magokjungang 8-ro 3-gil
  • Gangseo-gu
  • Seoul, Seodaemun-gu
  • South Korea
+82

JS Link Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

JS Link Stock Performance

As of 20-Nov-2026, JS Link’s stock price is $11.84. Its current market cap is $434M with 36.6M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$11.84 $12.52 $9.64 - $33.81 $434M 36.6M 187K -$0.14

JS Link Financials Summary

As of 30-Jun-2026, JS Link has a trailing 12-month revenue of $15.7M.

In Thousands,
USD
TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 833,234 387,754 90,015 43,306
Revenue 15,697 13,573 11,659 16,788
EBITDA 1,492 (8,425) (6,651) (3,137)
Net Income (3,651) (11,556) (7,917) (4,280)
Total Assets 121,643 85,441 36,923 30,075
Total Debt 41,213 30,078 12,995 3,355
Public Fundamental Data provided by Morningstar, Inc. disclaimer

JS Link Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore JS Link‘s full profile, request access.

Request a free trial

JS Link Patents

JS Link Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2020013347-A1 Composition, kit and microarray for personal identification, comprising at least 22 marker polynucleotides, and method for obtaining information required for personal identification using same Inactive 09-Jul-2018
AU-2003277721-A1 Beta-nitrostyrene compound and telomerase inhibitor having an anticancer activity Inactive 15-Nov-2002
AU-2003277721-A8 Beta-nitrostyrene compound and telomerase inhibitor having an anticancer activity Inactive 15-Nov-2002
WO-2004046081-A1 Beta-nitrostyrene compound and telomerase inhibitor having an anticancer activity Inactive 15-Nov-2002 C07C205/04

JS Link Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

JS Link Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore JS Link‘s full profile, request access.

Request a free trial

JS Link Investments (4)

JS Link’s most recent deal was a Joint Venture with Lynas-JS Link. The deal was made on 07-Jul-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Lynas-JS Link 07-Jul-2026 Joint Venture Industrial Supplies and Parts
DNA Link (25,000 Square Meters Of Factory Site In Yesan-gun, South Korea) 28-Nov-2024 Corporate Asset Purchase Buildings and Property
K-Seung Construction (37,188.67 Square Meters of Land and Building in Yesan, South Korea) 28-Nov-2024 Corporate Asset Purchase Buildings and Property
Minero 29-Jan-2024 Corporate Environmental Services (B2B)
To view JS Link’s complete investments history, request access »

JS Link ESG

Risk Overview

Risk Rating

Updated November, 04, 2026

43.75 | Severe Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,593

Rank

Percentile

Pharmaceuticals

Industry

of 852

Rank

Percentile

Biotechnology

Subindustry

of 431

Rank

Percentile

To view JS Link’s complete esg history, request access »

JS Link FAQs

  • When was JS Link founded?

    JS Link was founded in 2000.

  • Where is JS Link headquartered?

    JS Link is headquartered in Seoul, South Korea.

  • What is the size of JS Link?

    JS Link has 84 total employees.

  • What industry is JS Link in?

    JS Link’s primary industry is Biotechnology.

  • Is JS Link a private or public company?

    JS Link is a Public company.

  • What is JS Link’s stock symbol?

    The ticker symbol for JS Link is 127120.

  • What is the current stock price of JS Link?

    As of 20-Nov-2026 the stock price of JS Link is $11.84.

  • What is the current market cap of JS Link?

    The current market capitalization of JS Link is $434M.

  • What is JS Link’s current revenue?

    The trailing twelve month revenue for JS Link is $15.7M.

  • What is JS Link’s annual earnings per share (EPS)?

    JS Link’s EPS for 12 months was -$0.14.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process